We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BR icon
6301
CALL
Broadridge
BR
$19.5B
$299K ﹤0.01%
3,300
-3,000
-48% -$262K
CCOI icon
6302
CALL
Cogent Communications
CCOI
$579M
$299K ﹤0.01%
6,600
-2,600
-28% -$124K
GIB icon
6303
CALL
CGI
GIB
$15.2B
$299K ﹤0.01%
+5,500
New +$293K
ICFI icon
6304
ICF International
ICFI
$1.59B
$299K ﹤0.01%
5,687
-4,117
-42% -$222K
ESL
6305
CALL
DELISTED
Esterline Technologies
ESL
$299K ﹤0.01%
+4,000
New +$329K
CMRE icon
6306
CALL
Costamare
CMRE
$1.77B
$298K ﹤0.01%
51,700
+16,000
+45% +$94.8K
CVE icon
6307
CALL
Cenovus Energy
CVE
$57.2B
$298K ﹤0.01%
32,600
-6,900
-17% -$67K
IMMR icon
6308
PUT
Immersion
IMMR
$249M
$298K ﹤0.01%
42,200
+27,900
+195% +$202K
P
6309
CALL
Everpure Inc
P
$39.3B
$298K ﹤0.01%
18,800
-6,000
-24% -$100K
KND
6310
PUT
DELISTED
Kindred Healthcare
KND
$298K ﹤0.01%
30,700
+20,400
+198% +$152K
TEP
6311
PUT
DELISTED
Tallgrass Energy Partners, LP
TEP
$298K ﹤0.01%
6,500
+600
+10% +$27.2K
PSXP
6312
CALL
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$298K ﹤0.01%
5,700
+1,200
+27% +$59.8K
ACHC icon
6313
CALL
Acadia Healthcare
ACHC
$2.87B
$297K ﹤0.01%
9,100
-4,800
-35% -$166K
CLLS
6314
CALL
Cellectis
CLLS
$296M
$297K ﹤0.01%
10,200
-1,200
-11% -$32.7K
IRDM icon
6315
Iridium Communications
IRDM
$5.32B
$297K ﹤0.01%
25,147
-10,137
-29% -$117K
IWC icon
6316
PUT
iShares Micro-Cap ETF
IWC
$1.52B
$297K ﹤0.01%
3,100
+800
+35% +$75.8K
RDWR icon
6317
CALL
Radware
RDWR
$1.23B
$297K ﹤0.01%
+15,300
New +$290K
TEO icon
6318
PUT
Telecom Argentina
TEO
$5.75B
$297K ﹤0.01%
8,100
-12,700
-61% -$437K
MDRX
6319
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
$297K ﹤0.01%
+20,400
New +$283K
CKH
6320
DELISTED
Seacor Holdings Inc.
CKH
$297K ﹤0.01%
6,428
-1,110
-15% -$51K
ABAX
6321
PUT
DELISTED
Abaxis Inc
ABAX
$297K ﹤0.01%
6,000
-2,200
-27% -$105K
CEF icon
6322
Sprott Physical Gold and Silver Trust
CEF
$8.32B
$296K ﹤0.01%
+22,078
New +$291K
MNRO icon
6323
PUT
Monro
MNRO
$359M
$296K ﹤0.01%
5,200
+1,500
+41% +$78.1K
MTBL
6324
PUT
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$296K ﹤0.01%
95,000
+41,333
+77% +$123K
MLNT
6325
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$296K ﹤0.01%
+3,748
New +$277K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.